Going from Science to Scale – Commercializing Aflasafe® in 11 African Countries
Description:
The Aflasafe® Technology Transfer and Commercialization Initiative (ATTC) is pleased to host a panel discussion on the commercialization of Aflasafe® . Join our panelists in an open dialogue as we provide a light breakfast to jumpstart the Borlaug Dialogue.
Panel Session Overview:
Aflasafe® has the potential to create prosperity for millions of African smallholder farmers by efficiently reducing aflatoxins levels by 80 to 99 percent at the time of harvest. In Nigeria alone, the negative economic and monetized health impact of aflatoxin in 2014 was $985 million, or 1.2% of total GDP.
The Aflasafe® Technology Transfer and Commercialization Initiative (ATTC) implemented by the International Institute for Tropical Agriculture (IITA) in collaboration with Chemonics International and Dalberg Global Development Advisors, with support from USAID and the Bill and Melinda Gates Foundation (BMGF), aims at building dynamic private sector partnerships to significantly increase sales of Aflasafe®, achieving their profit goals, and driving prosperity for thousands of smallholder farmers.
This panel will discuss the dynamic design of the program, progress towards program goals, and how our consortium acts as strategic advisors to IITA, intelligently selecting, supporting, and accelerating some of the continent’s most dynamic private sector firms to market and distribute Aflasafe® .
ATTC Program Overview:
The program supports Aflasafe® commercialization through a three pillar support system:
- Identification of robust private sectors manufacturing and distribution partners.
- Provide policy recommendations to national governments to restrict trade of aflatoxin-contaminated goods.
- Support investors to market aflasafe to smallholder farmers by promoting price premiums for aflatoxin-safe products and raising awareness of the negative health consequences of aflatoxin-laden foods.
Aflasafe® Program Goals:
One year after start-up, the team will discuss the project’s progress and lessons learned towards the following goals:
- Secure partner commitments to treat at least 100,000 hectares of land in Nigeria, Senegal, and Kenya by June 2017.
- Commercialize Aflasafe® and treat at least 500,000 hectares of land in 11 target countries throughout Africa.
- Provide trainings to smallholder farmers to ensure transfer and sustainable uptake of Aflasafe® for target crops.
Panel Participants:
- Eric Reading, Executive Vice President, Chemonics International
- Abdou Konlambigue, Managing Director ATTC, IITA
- Mario Kerby, Director, Chemonics
- Orin Hasson, Senior Program Officer, The Gates Foundation
- Angela Hansen, Advisor, Dalberg Global Development Advisors
- Kenton Dashiell, Deputy Director General, Partnerships for Delivery, IITA